Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11805519 | 1.00 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL6058455 | 1.00 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL22324339 | 1.00 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL11805525 | 1.00 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL11805533 | 1.00 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL6049107 | 0.98 | HDAC4 (0.48) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| Ammonia Solution, Strong SCHEMBL27681740 | 0.96 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL340678 | 0.92 | HDAC4 (0.47) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL15522251 | 0.86 | ALDH1A1 (0.44) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL9443741 | 0.85 | TSHR (0.46) | HDAC4HDAC2HDAC8HDAC6CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11426339-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-08-30 | — | — | US | disclosed |
| US-20220204447-A1 | CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS | NATIONAL SCIENCE FOUNDATION | 2022-06-30 | — | — | US | disclosed |
| EP-3793514-B1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2022-04-20 | — | — | EP | disclosed |
| EP-3793514-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2021-03-24 | — | — | EP | disclosed |
| US-20210045985-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204447-A1 | CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS | DHPS, PCBP1, PNKP | HDAC4 1879/4885HDAC2 2908/4885HDAC8 2541/4885 |
| US-11426339-B2 | Organic compounds | OR51E2, OR10J3, ELOC | HDAC4 2228/4885HDAC2 1715/4885HDAC8 3506/4885 |
| US-20210045985-A1 | ORGANIC COMPOUNDS | OR51E2, OR10J3, ELOC | HDAC4 2228/4885HDAC2 1715/4885HDAC8 3506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.